Evaluation of individual medical services 2011

Project co-operation: LBI-HTA staff for individual reviews
Duration: January 2011 - April 2011

Suggested by: BMG
Publication of reports: on July, 15th 2011

Objective:
Each year, the Austrian Ministry of Health receives suggestions for numerous new medical interventions to get reimbursed. The aim of this project is to evaluate the efficacy and safety of interventions, suggested to be included into the MEL (German for: individual medical services) catalogue. Themes (interventions) were prioritized by the Ministry of Health and contracted out to the LBI-HTA.

Method:
The assessments are based on systematic reviews for each intervention and a summary of the scientific evidence according to the GRADE scheme. Since 2009 there is a cooperation with the german NUB process, which also appraises with the same method for both countries relevant new medical interventions at the same time.

MEL- Interventions 2011:

• DSD 43: Vascular-Endothelial-Growth-Factor-Inhibitors (anti-VEGF) in the Management of Diabetic Macular Oedema.
  German: https://eprints.aihta.at/916  
  English: https://eprints.aihta.at/917
• DSD 44: Percutaneous left atrial appendage closure for the prevention of thromboembolic events in patients with atrial fibrillation
  https://eprints.aihta.at/918
• DSD 45: Renal denervation in patients with essential hypertonia
  https://eprints.aihta.at/919
• DSD 46: Mechanical percutaneous transluminal cerebral clot retrieval devices in acute ischemic stroke: Systematic Review on efficacy and safety
  https://eprints.aihta.at/920
• DSD 47: Selective internal radiotherapy using yttrium-90 microspheres for primary and secondary liver malignancies.
  German: https://eprints.aihta.at/921 
  English: https://eprints.aihta.at/922 

+ 1 Update:

• DSD 18/Update 2011: Percutaneous aortic valve replacement (with a side note to hybrid operating rooms)
  https://eprints.aihta.at/923

all MEL Assessments 2008-2010